Shenzhen New Industries Biomedical Engineering Co. Ltd Financials

Market Capitalization CN¥46.28 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	26.79
Forward PE	20.97
Price to Sales TTM	CN¥9.72
Price to Book MRQ	CN¥5.05
Enterprise to Revenue	9.22
Enterprise to EBITDA	22.35

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	36.27%
Operating Margin	37.15%
Return on Assets TTM	11.39%
Return on Equity TTM	19.56%

Income Statement

Revenue TTM	CN¥4,548,748,800
Revenue per Share TTM	CN¥5.79
Quarterly Revenue Growth	3.30%
Gross Profit TTM	CN¥3,154,593,792
EBITDA	CN¥1,932,780,219
Net Income to Common TTM	CN¥1,649,667,968
Diluted EPS TTM	CN¥2.10
Quarterly Earnings Growth YoY	-9.70%

Balance Sheet

Total Cash MRQ	CN¥2,259,724,800
Total Cash per Share MRQ	CN¥2.88
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	0.04
Current Ratio MRQ	7.65
Book Value per Share MRQ	CN¥11.13

Cash Flow

Operating Cash Flow TTM	CN¥1,462,564,864
Levered Free Cash Flow TTM	CN¥150,221,232

300832 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	785,718,785
Float Shares	323,967,569
Avg 10 Volume	2,139,535
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	48.57%
% Held by Institutions	23.62%

Stock Price Summary

Beta	-0.35
Fifty Two Week Low	CN¥49.01
Fifty Two Week High	CN¥71.51
Fifty Two Week Change	-18.01%
Day 50 MA	CN¥60.59
Day 200 MA	CN¥59.32

Dividends and Splits

Forward Annual Dividend Rate	CN¥5.20
Forward Annual Dividend Yield	9.24%
Trailing Annual Dividend Rate	CN¥1.30
Trailing Annual Dividend Yield	2.31%
Payout Ratio	61.92%
Dividend Date
Ex Dividend Date	2025-05-28
Last Split Factor
Last Split Date	2021-05-21